Riverstone Holdings (SGX:AP4) Research & Development: S$0.0 Mil (TTM As of Dec. 2025)


SGX:AP4 Riverstone Holdings Ltd SGX:AP4
64 GF Score
Price S$0.83
GF Value S$0.86
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Riverstone Holdings Research & Development?

Riverstone Holdings SGX:AP4 +0.61% 64 Research & Development is S$0.0 Mil as of Dec. 2025. GuruFocus rates SGX:AP4 with a GF Score™ of 64/100 and a GF Value™ of S$0.86 (Fairly Valued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Riverstone Holdings's Research & Development for the three months ended in Dec. 2025 was S$0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was S$0.0 Mil.

Riverstone Holdings  (SGX:AP4) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Riverstone Holdings Research & Development Related Terms

Riverstone Holdings Research & Development Historical Data

* Premium members only.

The historical data trend for Riverstone Holdings's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Riverstone Holdings Research & Development Chart

Riverstone Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Riverstone Holdings Quarterly Data
Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
SGX:AP4
64GF Score
Riverstone Holdings Ltd SGX:AP4
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Riverstone Holdings Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was S$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of S$0.0 Mil mean?
Riverstone Holdings (SGX:AP4) has a Research & Development of S$0.0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Riverstone Holdings and its competitors.
Is Riverstone Holdings' Research & Development too high?
Riverstone Holdings' current Research & Development is S$0.0 Mil. Overall, Riverstone Holdings has a GF Score™ of 64/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Riverstone Holdings' Research & Development compare to ISRG and BDX?
Riverstone Holdings' Research & Development of S$0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Riverstone Holdings and its competitors. Riverstone Holdings's current Research & Development is S$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Riverstone Holdings stock overvalued right now?
Based on GuruFocus' analysis, Riverstone Holdings (SGX:AP4) is currently considered Fairly Valued. The stock's GF Value™ is S$0.86, compared to a current price of S$0.83 — trading 3.5% below its estimated fair value. The current Research & Development is S$0.0 Mil. Riverstone Holdings' overall GF Score™ is 64/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Riverstone Holdings (SGX:AP4), the current Research & Development is S$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Riverstone Holdings (SGX:AP4) Overvalued in 2026?

Based on GuruFocus' analysis, Riverstone Holdings stock appears to be undervalued. The current stock price of S$0.83 is trading 3.5% below its estimated GF Value™ of S$0.86. GuruFocus considers Riverstone Holdings to be Fairly Valued.

Key valuation signals for SGX:AP4:

  • Research & Development: S$0.0 Mil
  • GF Value™: S$0.86 vs. price of S$0.83 (3.5% below fair value)
  • GF Score™: 64/100 with 5 warning signs

No single metric tells the full story. See the SGX:AP4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Riverstone Holdings Business Description

Address 362 Upper Paya Lebar Road, No. 03-14 Da Jin Factory Building, Singapore, SGP, 534963
Riverstone Holdings Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the manufacture and sales of gloves and non-glove consumables such as finger cots, static shielding bags, face masks, wipers, and packaging materials. The group's products are widely qualified and used in the Hard Disk Drive, and semiconductor industries. It operates in three segments based on its geography: Malaysia, Thailand, China, Singapore, and Others, of which the majority of its revenue comes from Malaysia.
64GF Score

Get the complete analysis for SGX:AP4

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

S$0.83
Price
S$0.86
GF Value